Alpha IVF Group Bhd

Alpha IVF Group Bhd Equity

The The Equity of Alpha IVF Group Bhd (ALPHA.KL) as of Nov 5, 2026 is 189.74 M MYR. In the previous year, The Equity was 198.04 M MYR — a change of -4.19% (lower).

Equity

189.74 MMYR

YoY

-4.19%

Last updated:

In 2026, Alpha IVF Group Bhd's equity was 189.74 M MYR, a -4.19% increase from the 198.04 M MYR equity in the previous year.

The Alpha IVF Group Bhd Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
16.90 M MYR
Jan 1, 2021
33.71 M MYR
Jan 1, 2022
40.47 M MYR
Jan 1, 2023
51.60 M MYR
Jan 1, 2024
187.43 M MYR
Jan 1, 2025
198.04 M MYR
Jan 1, 2026
189.74 M MYR
The Alpha IVF Group Bhd Equity history
YEAREquityYoY
189.74 MMYR-4.19%
198.04 MMYR+5.66%
187.43 MMYR+263.26%
51.60 MMYR+27.50%
40.47 MMYR+20.04%
33.71 MMYR+99.49%
16.90 MMYR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alpha IVF Group Bhd Stock analysis

What does Alpha IVF Group Bhd do? Alpha IVF Group Bhd generates revenue through its comprehensive fertility services, including assisted reproductive technologies (ART) and related medical treatments. The company operates specialist fertility care centers across Malaysia, offering services such as fertility assessment, diagnostics, testing, monitoring, preconception care, and counseling. Medical specialists in obstetrics and gynecology provide ART procedures and prescribe fertility drugs, forming the core of the company's service offerings. The primary customers are individuals or couples seeking solutions for infertility challenges, with the company's focus on technology-driven fertility care and research. The firm's business model centers on delivering end-to-end fertility solutions through its network of specialized centers. ART encompasses a range of medical technologies and laboratory procedures designed to assist infertility, supported by the company's in-house labs and technology infrastructure. Revenue is derived from the provision of these services, including diagnostics, monitoring, and prescription of fertility-related medications. The company targets patients requiring advanced fertility treatments, leveraging its expertise in obstetrics and gynecology to address infertility through both medical and technological approaches. Alpha IVF Group Bhd differentiates itself through its integrated approach to fertility care, combining medical expertise with laboratory technology. The company's services are structured around the needs of patients facing infertility, offering a full spectrum of support from initial assessment to ongoing care. By focusing on ART and related services, the company positions itself as a provider of specialized fertility solutions within the healthcare sector, with revenue streams directly tied to the delivery of these services to its patient base. Alpha IVF Group Bhd is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Alpha IVF Group Bhd's Equity

Alpha IVF Group Bhd's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Alpha IVF Group Bhd's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Alpha IVF Group Bhd's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Alpha IVF Group Bhd's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Alpha IVF Group Bhd’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Alpha IVF Group Bhd stock

The Equity of Alpha IVF Group Bhd is 189.74 M MYR in 2026.

The Equity of Alpha IVF Group Bhd changed from 198.04 M MYR to 189.74 M MYR, representing a -4.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Alpha IVF Group Bhd since 2006 – with annual values, charts, and detailed analysis.

The Equity's MYR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Alpha IVF Group Bhd historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Alpha IVF Group Bhd

All Key Metrics — Alpha IVF Group Bhd